Evidence map›Paper›PMID 32760059›Full record

ArticlePLoS neglected tropical diseases2020

Fasciola hepatica serine protease inhibitor family (serpins): Purposely crafted for regulating host proteases.

Carolina De Marco Verissimo, Heather L Jewhurst, Irina G Tikhonova, Rolf T Urbanus, Aaron G Maule, John P Dalton, Krystyna Cwiklinski

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. In vitro co-culture ofVirulence · 2025
    Article
  5. Article
  6. Article
  7. Infection and immunity · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. An Update on the Pathogenesis of Fascioliasis: What Do We Know?Research and reports in tropical medicine · 2024
    Review
  12. Effects ofInfection and immunity · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Carolina De Marco VerissimoCentre for One Health and Ryan Institute, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.ORCID 0000-0003-1762-6387
Heather L JewhurstCentre for One Health and Ryan Institute, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.
Irina G TikhonovaSchool of Pharmacy, Medical Biology Centre, Queen's University Belfast, Belfast, United Kingdom.
Rolf T UrbanusThrombosis and Hemostasis Laboratory, Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands.ORCID 0000-0002-1601-9393
Aaron G MauleMicrobe & Pathogen Biology, The Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, United Kingdom.
John P DaltonCentre for One Health and Ryan Institute, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.ORCID 0000-0003-3829-9186
Krystyna CwiklinskiCentre for One Health and Ryan Institute, School of Natural Sciences, National University of Ireland Galway, Galway, Ireland.ORCID 0000-0001-5577-2735
Ollscoil na Gaillimhe – University of Galway · IEQueen's University Belfast · GBUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine protease inhibitors (serpins) regulate proteolytic events within diverse biological processes, including digestion, coagulation, inflammation and immune responses. The presence of serpins in Fasciola hepatica excretory-secretory products indicates that the parasite exploits these to regulate proteases encountered during its development within vertebrate hosts. Interrogation of the F. hepatica genome identified a multi-gene serpin family of seven members that has expanded by gene duplication and divergence to create an array of inhibitors with distinct specificities. We investigated the molecular properties and functions of two representatives, FhSrp1 and FhSrp2, highly expressed in the invasive newly excysted juvenile (NEJ). Consistent with marked differences in the reactive centre loop (RCL) that executes inhibitor-protease complexing, the two recombinant F. hepatica serpins displayed distinct inhibitory profiles against an array of mammalian serine proteases. In particular, rFhSrp1 efficiently inhibited kallikrein (Ki = 40 nM) whilst rFhSrp2 was a highly potent inhibitor of chymotrypsin (Ki = 0.07 nM). FhSrp1 and FhSrp2 are both expressed on the NEJ surface, predominantly around the oral and ventral suckers, suggesting that these inhibitors protect the parasites from the harmful proteolytic effects of host proteases, such as chymotrypsin, during invasion. Furthermore, the unusual inhibition of kallikrein suggests that rFhSrp1 modulates host responses such as inflammation and vascular permeability by interfering with the kallikrein-kinin system. A vaccine combination of rFhSrp1 and rFhSrp2 formulated in the adjuvant Montanide ISA 206VG elicited modest but non-significant protection against a challenge infection in a rat model, but did induce some protection against liver pathogenesis when compared to a control group and a group vaccinated with two well-studied vaccine candidates, F. hepatica cathepsin L2 and L3. This work highlights the importance of F. hepatica serpins to regulate host responses that enables parasite survival during infection and, coupled with the vaccine data, encourages future vaccine trials in ruminants.

Indexed as

Amino Acid SequenceAnimalsFasciola hepaticaGene Expression RegulationHost-Parasite InteractionsSerine Proteinase InhibitorsSerpinsSerine Proteinase InhibitorsSerpins

Identifiers

PMID32760059
PMCPMC7437470
OpenAlexW3047064804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.